Condition

Clinical trials for Obesity (BMI>30)

Active public studies that list Obesity (BMI>30) as a condition.

16active studies

2recruiting now

8countries represented

2largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Overweight (BMI > 25), Obesity (BMI>30)Condition

Avocado, ControlTreatment

United States2 locations

Midwest Center for Metabolic and Cardiovascular ResearchSponsor

Updated 2026-08-27 · NCT07566325See eligibility →

Recruiting nowNot applicable

The Effect of Fasting on Peak Fat Oxidation, Mitochondrial Coupling and Extracellular Matrix

Fasting, Obesity (BMI>30)Condition

DietTreatment

Denmark1 locations

University of CopenhagenSponsor

Updated 2026-07-09 · NCT07692646See eligibility →

Opening soonNot applicable

Pilot Study of Endoscopic Sleeve Gastroplasty for Obese Patients With Heart Failure and Preserved Ejection Fraction

Obesity (BMI>30), Heart Failure With Preserved Ejection Fraction (HFPEF)Condition

Endoscopic sleeve gastroplasty (ESG)Treatment

United States1 locations

Cedars-Sinai Medical CenterSponsor

Updated 2026-09-01 · NCT07798219See eligibility →

Opening soonNot applicable

Effect of Tocopherol and Ascorbic Acid on Neuroinflammation Markers Associated With Neuropeptide Expression in the AgRP/NPY and POMC Pathways in Mexican Population With Obesity

Obesity (BMI>30), NeuroinflammationCondition

Ascorbic acid (Vitamin C), tocopherol alphaTreatment

Mexico1 locations

Autonomous University of MorelosSponsor

Updated 2026-08-24 · NCT07782411See eligibility →

Opening soonNot applicable

Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)

Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)Condition

ESG with OverStitchTreatment

Locations pending0 locations

Boston Scientific CorporationSponsor

Updated 2026-08-21 · NCT07639684See eligibility →

Opening soonPhase 4

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

Obesity (BMI>30)Condition

Dual GIP/GLP-1 Receptor Agonist Tirzepatide, Resistance TrainingTreatment

Germany1 locations

Technical University of MunichSponsor

Updated 2026-08-20 · NCT07777575See eligibility →

Opening soonNot applicable

Inositol and Metformin Administration in Mediterranean Diet and Low-Carbohydrate Diets in Women With PCOS

PCOS (Polycystic Ovary Syndrome), Insulin ResistanceCondition

Metformin, İnositolTreatment

Turkey (Türkiye)1 locations

Dicle UniversitySponsor

Updated 2026-08-18 · NCT07770711See eligibility →

Opening soonPhase 2

Semaglutide for Low Back Pain

Lower Back Pain, Obesity (BMI>30)Condition

Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector)Treatment

United States2 locations

Washington University School of MedicineSponsor

Updated 2026-07-28 · NCT07731256See eligibility →

Opening soonEarly Phase 1

Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity

Obesity (BMI>30), Insulin ResistanceCondition

human insulinTreatment

United States1 locations

University of Missouri-ColumbiaSponsor

Updated 2026-07-28 · NCT07653464See eligibility →

Opening soonNot applicable

Plasma Taurine in Older Women With Obesity: Impact of Metabolic Phenotype and Combined Exercise

Obesity (BMI>30), Metabolically Healthy ObesityCondition

Physical Training of 16 weeksTreatment

Locations pending0 locations

University of Sao PauloSponsor

Updated 2026-07-20 · NCT07711899See eligibility →

Opening soonNot applicable

Allurion Gastric Balloon PAS

Obesity (BMI>30), Obesity & OverweightCondition

Active Elipse DeviceTreatment

Locations pending0 locations

Allurion TechnologiesSponsor

Updated 2026-07-06 · NCT07684664See eligibility →

Opening soonNot applicable

OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders

Obesity (BMI>30)Condition

Therapeutic patient educationTreatment

Canada1 locations

CHU de Quebec-Universite LavalSponsor

Updated 2026-06-25 · NCT07668661See eligibility →

Opening soonNot applicable

Machine Learning Prediction of Respiratory Muscle Changes and Ventilatory Responses After Incretin-Based Therapy in Obesity

Obesity (BMI>30)Condition

Incretin-based therapyTreatment

Locations pending0 locations

Biruni UniversitySponsor

Updated 2026-06-23 · NCT07663591See eligibility →

Opening soonNot applicable

Comparison Between the Health Effects of an AI-driven Model With Those of Human Professional Guidelines for the Treatment of Obesity

Obesity (BMI>30)Condition

AI-assisted dietitian group (combination), A dietitian-led group (human)Treatment

Locations pending0 locations

Texas Tech UniversitySponsor

Updated 2026-05-07 · NCT07557979See eligibility →

Invitation onlyNot applicable

MRI Assessment of Body Composition in Bariatric Surgery

Obesity (BMI>30)Condition

MRITreatment

Poland1 locations

University of Warmia and Mazury in OlsztynSponsor

Updated 2026-07-17 · NCT07711925See eligibility →

Active, not recruitingNot applicable

Exercise and Taurine Supplementation on Intramuscular Fat in Older Women With Obesity

Obesity (BMI>30)Condition

Concurrent Exercise Training, TaurineTreatment

Brazil1 locations

University of Sao PauloSponsor

Updated 2026-07-28 · NCT07730255See eligibility →

Related conditions

Obesity1,102 Obesity & Overweight220 Overweight205 Overweight and Obesity130 Type 2 Diabetes108 Hypertension107

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.